Click on the subcategory below to find drug monographs for that particular area.
Make prescribing decisions with our comparative charts and treatment algorithms.
Download or print easy-to-read disease leaflets for your patients.
Atriphen has been recalled due to the possibility of causing a severe allergic reaction from two undeclared allergens.
The FDA has accepted for review the Biologics License Application for ragweed pollen sublingual allergy immunotherapy tablet.
Parental sucking of their infant's pacifier is associated with a reduced risk of allergy development.
For U.S. children aged younger than 18 years, the prevalence of allergies increased from 1997-2011, with age, race/ethnicity, and income all affecting the prevalence.
The goal of this program is to improve the management of the difficult airway.
2.00 AMA PRA Category 1 Credit(s)TM
This activity will review the statistics related to incidence/prevalence of asthma and COPD and present the signs, symptoms, and treatment options for asthma and COPD. This activity is accredited for 1.50 CNE credit of which 1.50 is pharmacology credit.
1.50 CE for Nurses
This program will discuss the pathophysiology of asthma and associated small airway inflammation, describe the relevance of small airway inflammation and implications for effective pharmacologic therapy, and review the current recommendations on the use of spirometry for the treatment of patients with asthma.
1.00 AMA PRA Category 1 Credit(s)TM